Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass

Clinical trial NCT07272837 · RECRUITING

Trial details

NCT number: NCT07272837
Sponsor: University of Alberta
Status: RECRUITING
Study type: OBSERVATIONAL

Type 2 Diabetes Obesity Semaglutide GLP-1 Diabetes

Start date: 2026-05-15
Primary completion: 2027-12-31
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.